» Authors » Alain C Borczuk

Alain C Borczuk

Explore the profile of Alain C Borczuk including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 127
Citations 5232
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Sinha A, Zou Y, Patel A, Yoo S, Jiang F, Sato T, et al.
Cancers (Basel) . 2022 Feb; 14(3). PMID: 35158979
Lung cancer is the most common cause of cancer-related deaths in both men and women, accounting for one-quarter of total cancer-related mortality globally. Lung adenocarcinoma is the major subtype of...
22.
Nicholson A, Tsao M, Beasley M, Borczuk A, Brambilla E, Cooper W, et al.
J Thorac Oncol . 2021 Nov; 17(3):362-387. PMID: 34808341
The 2021 WHO Classification of Thoracic Tumours was published earlier this year, with classification of lung tumors being one of the chapters. The principles remain those of using morphology first,...
23.
Borczuk A
Mod Pathol . 2021 Oct; 35(Suppl 1):28-35. PMID: 34615984
The pathologic evaluation of lung adenocarcinoma, because of greater understanding of disease progression and prognosis, has become more complex. It is clear that histologic growth patterns reflect indolent and aggressive...
24.
Thunnissen E, Motoi N, Minami Y, Matsubara D, Timens W, Nakatani Y, et al.
Histopathology . 2021 Aug; 80(3):457-467. PMID: 34355407
Elastin and collagen are the main components of the lung connective tissue network, and together provide the lung with elasticity and tensile strength. In pulmonary pathology, elastin staining is used...
25.
Tang X, Uhl S, Zhang T, Xue D, Li B, Vandana J, et al.
Cell Metab . 2021 Jun; 33(8):1577-1591.e7. PMID: 34081913
Recent clinical data have suggested a correlation between coronavirus disease 2019 (COVID-19) and diabetes. Here, we describe the detection of SARS-CoV-2 viral antigen in pancreatic beta cells in autopsy samples...
26.
Altorki N, McGraw T, Borczuk A, Saxena A, Port J, Stiles B, et al.
Lancet Oncol . 2021 May; 22(6):824-835. PMID: 34015311
Background: Previous phase 2 trials of neoadjuvant anti-PD-1 or anti-PD-L1 monotherapy in patients with early-stage non-small-cell lung cancer have reported major pathological response rates in the range of 15-45%. Evidence...
27.
Rendeiro A, Ravichandran H, Bram Y, Chandar V, Kim J, Meydan C, et al.
Nature . 2021 Mar; 593(7860):564-569. PMID: 33780969
Recent studies have provided insights into the pathology of and immune response to COVID-19. However, a thorough investigation of the interplay between infected cells and the immune system at sites...
28.
Park J, Foox J, Hether T, Danko D, Warren S, Kim Y, et al.
bioRxiv . 2021 Mar; PMID: 33758858
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus has infected over 115 million people and caused over 2.5 million deaths worldwide. Yet, the molecular mechanisms underlying the clinical manifestations...
29.
Borczuk A
Curr Opin Pulm Med . 2021 Jan; 27(3):184-192. PMID: 33399353
Purpose Of Review: COVID-19 lung injury is a common manifestation of severe illness. Lung tissue examination has been largely derived from autopsy - a combination of case reports, small and...
30.
Borczuk A
Arch Pathol Lab Med . 2020 Dec; 145(1):10. PMID: 33367668
No abstract available.